Literature DB >> 7811043

Effect of bismuth subsalicylate on ciprofloxacin bioavailability.

L Rambout1, J Sahai, K Gallicano, L Oliveras, G Garber.   

Abstract

A single oral dose of 528 mg of bismuth subsalicylate (30 ml of Pepto-Bismol) had no significant effect on the plasma pharmacokinetics of a single oral dose of 750 mg of ciprofloxacin administered to 12 healthy volunteers (six men and six women). These results suggest that ciprofloxacin bioavailability will not be significantly decreased by single doses of bismuth subsalicylate when the two medications are administered simultaneously.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811043      PMCID: PMC284708          DOI: 10.1128/AAC.38.9.2187

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  A distribution-free procedure for the statistical analysis of bioequivalence studies.

Authors:  D Hauschke; V W Steinijans; E Diletti
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-02

2.  The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.

Authors:  D E Nix; W A Watson; L Handy; R W Frost; D L Rescott; H R Goldstein
Journal:  Pharmacotherapy       Date:  1989       Impact factor: 4.705

Review 3.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

4.  Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture.

Authors:  K S Albert; R D Welch; K A DeSante; A R DiSanto
Journal:  J Pharm Sci       Date:  1979-05       Impact factor: 3.534

5.  Effect of antacids in didanosine tablet on bioavailability of isoniazid.

Authors:  K Gallicano; J Sahai; G Zaror-Behrens; A Pakuts
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

Authors:  R E Polk; D P Healy; J Sahai; L Drwal; E Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 7.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

8.  Norfloxacin interaction with antacids and minerals.

Authors:  N R Campbell; M Kara; B B Hasinoff; W M Haddara; D W McKay
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

9.  Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin.

Authors:  R W Frost; K C Lasseter; A J Noe; E C Shamblen; J T Lettieri
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 10.  Drug-drug interactions with ciprofloxacin and other fluoroquinolones.

Authors:  R E Polk
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

View more
  4 in total

1.  Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.

Authors:  Antonio Francesco Ciccaglione; Luigina Cellini; Laurino Grossi; Leonardo Marzio
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

2.  Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay.

Authors:  Mahmoud Mohamed Issa; R'afat Mahmoud Nejem; Naser Said El-Abadla; Mohamed Khamis El-Naby; Abeer Ahmed Roshdy; Zainab Assan Kheiralla
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  In vitro-in vivo studies of the quantitative effect of calcium, multivitamins and milk on single dose ciprofloxacin bioavailability.

Authors:  Baishakhi Dey; Prakash Katakam; Fathi H Assaleh; Babu Rao Chandu; Shanta Kumari Adiki; Analava Mitra
Journal:  J Pharm Anal       Date:  2015-03-10

4.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.